Tumor immune microenvironment changes are associated with response to neoadjuvant chemotherapy and long-term survival benefits in advanced epithelial ovarian cancer: A pilot studyGuangming Cao, Lei Zhu, Jinfeng Li et al.|Frontiers in Immunology|2023Cited by 20